(1)
Breccia, M.; Alimena, G. SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs. MJHID 2014, 6, e2014003.